EHSI to Add Blood Disorder Treatment Module to
Medical iPhone App
April 26, 2010 09:06 AM Eastern Daylight Time
HOUSTON--(EON: Enhanced Online News)--Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) announced
that the Company is adding a module to incorporate at home diagnosis and monitoring of various blood disorders as
options to its new breakthrough medical iPhone app, currently in development. The module is being configured for
use with multiple approved devices, including one for home monitoring Prothrombin Time (PT)/INR, a critical test
performed to maintain the proper therapeutic range of oral anticoagulation therapies for patients taking such blood
thinning drugs as Coumadin® and Warfarin. The company is focusing on devices that are Medicare approved and
waived under the federal Clinical Laboratory Improvement Amendments (CLIA).
EHSI expects to announce their device compatibility vendors and equipment in the coming weeks.
Over 7 million people worldwide take oral anticoagulants to help reduce the body’s chances of forming harmful
blood clots. Just as self-testing of blood glucose has revolutionized the management of diabetes, self-testing for
Prothrombin Time has the potential to provide a positive impact on patient therapeutic outcomes as well as resulting
in fewer trips to labs and clinics for patients. Patients with mechanical heart valves and those suffering from atrial
fibrillation are among the many that could benefit from self-testing at home.
EHSI took the lead in the new mobile Telemedicine industry through their prior licensing and development of an
extraordinary mobile cellular-based communications platform for ambulances. This system was originally the
brainchild of Dr. Red Duke and was funded through a $20 million US Department of Defense grant to the University
of Texas Health Sciences Center at Houston. UT then engaged Texas A&M to fully develop the system.
More information about the cutting edge app can be seen at: